Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma
- 14 July 2008
- journal article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 18 (4), 652-659
- https://doi.org/10.1111/j.1525-1438.2007.01070.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in VivoJournal of Biological Chemistry, 2003
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Down-modulation of Bcl-X L , release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cellsBiochemical Pharmacology, 2002
- Honokiol and Magnolol Increase the Number of [3H]Muscimol Binding Sites Three-Fold in Rat Forebrain Membranes In Vitro Using a Filtration Assay, by Allosterically Increasing the Affinities of Low-Affinity SitesNeurochemical Research, 1999
- Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells.International Journal of Molecular Medicine, 1998
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cellsLife Sciences, 1994
- Studies on Inhibitors of Skin Tumor Promotion, IX. Neolignans from Magnolia officinalisJournal of Natural Products, 1991
- Studies on the Components of Magnolia obovata THUNB. II. On the Components of the Methanol Extract of the BarkYAKUGAKU ZASSHI, 1973